NCT00771342View on ClinicalTrials.gov

Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

August 31, 2009

Conditions
Tinea
Interventions
DRUG

Nitric Oxide

1% gaseous nitric oxide, delivered for 40 minutes daily for 3 consecutive days

DRUG

Nitrogen

Nitrogen gas, delivered topically for 40 minutes daily for 3 consecutive days

Trial Locations (1)

V5Z 1M9

Vancouver General Hospital, Vancouver

Sponsors
All Listed Sponsors
lead

Nitric BioTherapeutics, Inc

INDUSTRY

NCT00771342 - Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot) | Biotech Hunter | Biotech Hunter